| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 5862* | 2017 |
| Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop IG McKeith, D Galasko, K Kosaka, EK Perry, DW Dickson, LA Hansen, ... Neurology 47 (5), 1113-1124, 1996 | 4400 | 1996 |
| Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The Lancet 390 (10113), 2673-2734, 2017 | 2571 | 2017 |
| Vascular cognitive impairment J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ... The Lancet Neurology 2 (2), 89-98, 2003 | 1651 | 2003 |
| Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science EA Holmes, RC O'Connor, VH Perry, I Tracey, S Wessely, L Arseneault, ... The Lancet Psychiatry, 2020 | 1318 | 2020 |
| Putting brain training to the test AM Owen, A Hampshire, JA Grahn, R Stenton, S Dajani, AS Burns, ... Nature 465 (7299), 775-778, 2010 | 1228 | 2010 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1027 | 2016 |
| Atypical antipsychotics for aggression and psychosis in Alzheimer's disease CG Ballard, J Waite, J Birks Cochrane Database of Systematic Reviews, 2006 | 733 | 2006 |
| The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial C Ballard, ML Hanney, M Theodoulou, S Douglas, R McShane, ... The Lancet Neurology 8 (2), 151-157, 2009 | 675 | 2009 |
| Donepezil and memantine for moderate-to-severe Alzheimer's disease R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... New England Journal of Medicine 366 (10), 893-903, 2012 | 656 | 2012 |
| Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial J Fossey, C Ballard, E Juszczak, I James, N Alder, R Jacoby, R Howard Bmj 332 (7544), 756-761, 2006 | 607 | 2006 |
| Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa CG Ballard, JT O'Brien, EK Perry The Journal of clinical psychiatry 63 (7), 553-558, 2002 | 593 | 2002 |
| Overlap between pathology of Alzheimer disease and vascular dementia. RN Kalaria, C Ballard Alzheimer disease and associated disorders, 1999 | 560 | 1999 |
| Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies IG McKeith, CG Ballard, RH Perry, PG Ince, JT O’brien, D Neill, K Lowery, ... Neurology 54 (5), 1050-1058, 2000 | 522 | 2000 |
| Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial BS Husebo, C Ballard, R Sandvik, OB Nilsen, D Aarsland Bmj 343, 2011 | 507 | 2011 |
| White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging R Barber, P Scheltens, A Gholkar, C Ballard, I McKeith, P Ince, R Perry, ... Journal of Neurology, Neurosurgery & Psychiatry 67 (1), 66-72, 1999 | 490 | 1999 |
| Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial D Aarsland, C Ballard, Z Walker, F Bostrom, G Alves, K Kossakowski, ... The Lancet Neurology 8 (7), 613-618, 2009 | 484 | 2009 |
| Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial J Cummings, S Isaacson, R Mills, H Williams, K Chi-Burris, A Corbett, ... The Lancet 383 (9916), 533-540, 2014 | 483 | 2014 |
| Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial S Banerjee, J Hellier, M Dewey, R Romeo, C Ballard, R Baldwin, ... The Lancet 378 (9789), 403-411, 2011 | 470 | 2011 |
| A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry GB Karas, EJ Burton, S Rombouts, RA Van Schijndel, JT O’Brien, ... Neuroimage 18 (4), 895-907, 2003 | 458 | 2003 |
Aarsland DagProfessor, King's College LondonVahvistettu sähköpostiosoite verkkotunnuksessa kcl.ac.uk
